title: In vitro functional correction of the mutation responsible for murine severe combined immune deficiency by small fragment homologous replacement.
abstract: A homologous recombination (HR) approach for site-specific correction of mutations would be highly desirable for the treatment of genetic disorders if recombination efficiencies were sufficiently high as to permit a biological effect. Using a T cell thymoma line derived from severe combined immunodeficient (SCID) mice with a point mutation in the gene encoding the DNA-dependent protein kinase catalytic subunit (DNA-PKcs), we have shown that short DNA fragments (SDFs; 621 bases) can provide genotypic and functional correction of these cells. Double-stranded SDFs (dsSDFs) or single-stranded SDFs (ssSDFs) were designed to span the wild-type sequence of exon 85 in the DNA-PKcs gene and part of the 3' and 5' flanking intron regions. SCID cells were nucleofected with both single- and double-stranded wild-type SDF sequences. Corrected cells were selected on the basis of protection from radiation hypersensitivity that occurs as a consequence of the SCID mutation. Correction was mediated by both SDF forms (double and single stranded). These results indicate that SDFs can correct point mutations by HR with the possibility of harnessing ionizing radiation (IR) as a selection method to eliminate noncorrected cells and enrich for corrected SCID radioresistant cells.
authors.affiliation: University of Minnesota Cancer Center, and Department of Pediatrics, Division of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN 55455, USA. zayed001@umn.edu
authors.forename: Hatem
authors.initials: H
authors.lastname: Zayed
authors.forename: R Scott
authors.initials: RS
authors.lastname: McIvor
authors.forename: David L
authors.initials: DL
authors.lastname: Wiest
authors.forename: Bruce R
authors.initials: BR
authors.lastname: Blazar
mesh_terms: D024509:3' Flanking Region; D024506:5' Flanking Region; D000818:Animals; D020134:Catalytic Domain / Q000235:genetics; D004247:DNA / Q000235:genetics / Q000494:pharmacology*; D004249:DNA Damage; D004277:DNA, Single-Stranded / Q000494:pharmacology; D051747:DNA-Activated Protein Kinase / Q000235:genetics*; D004307:Dose-Response Relationship, Radiation; D005091:Exons; D018014:Gene Transfer Techniques; D016399:Lymphoma, T-Cell / Q000235:genetics* / Q000532:radiotherapy; D051379:Mice; D016513:Mice, SCID; D017354:Point Mutation; D011995:Recombination, Genetic; D017422:Sequence Analysis, DNA; D014407:Tumor Cells, Cultured
chemical_list: D004277:DNA, Single-Stranded; D004247:DNA; D051747:DNA-Activated Protein Kinase